Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CCR1 | P32246 | 2/20 | 0.50 |
| ▸ | CCR5 | P51681 | 2/20 | 0.50 |
| ▸ | CCR8 | P51685 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | METAP1 | P53582 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.50 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.50 |
| ▸ | NCF1 | P14598 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7540227 | 0.96 | ALDH1A1 (0.63) | ALDH1A1KDM4EMAPTPOLBLMNA | |
| Iodide SCHEMBL10806172 | 0.93 | ALDH1A1 (0.60) | ALDH1A1KDM4EMAPTPOLBLMNA | |
| Quinoxaline SCHEMBL29355228 | 0.92 | ALDH1A1 (0.58) | ALDH1A1KDM4EMAPTPOLBLMNA | |
| Quinoxaline SCHEMBL30320908 | 0.92 | ALDH1A1 (0.58) | ALDH1A1KDM4EMAPTPOLBLMNA | |
| SCHEMBL30099834 | 0.92 | ALDH1A1 (0.67) | ALDH1A1KDM4EMAPTPOLBLMNA | |
| Quinoxaline SCHEMBL5315 | 0.92 | ALDH1A1 (0.58) | ALDH1A1KDM4EMAPTPOLBLMNA | |
| Quinoxaline SCHEMBL6928518 | 0.92 | ALDH1A1 (0.58) | ALDH1A1KDM4EMAPTPOLBLMNA | |
| SCHEMBL8194 | 0.92 | ALDH1A1 (0.67) | ALDH1A1KDM4EMAPTPOLBLMNA | |
| Quinoxaline SCHEMBL4000710 | 0.89 | ALDH1A1 (0.55) | ALDH1A1KDM4EMAPTPOLBLMNA | |
| Quinoxaline SCHEMBL2431603 | 0.89 | ALDH1A1 (0.55) | ALDH1A1KDM4EMAPTPOLBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120217444-A1 | COMPOSITION AND METHOD FOR INHIBITING PREMATURE POLYMERIZATION | GENERAL ELECTRIC COMPANY | 2012-08-30 | — | — | US | disclosed |
| EP-1263856-B1 | STABILIZER COMPOSITION | BASF SE (DE) | 2009-06-24 | — | — | EP | disclosed |
| US-6908956-B2 | Stabilizer composition | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-21 | — | — | US | disclosed |
| US-20050090703-A1 | Continuous recovery of styrene from a styrene-containing mixture | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-28 | — | — | US | disclosed |
| US-6835288-B1 | Distillation; electron spin resonance; comprises 1-oxyl-2,2,6,6-tetramethylpiperidine as stabilizer | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-28 | — | — | US | disclosed |
| EP-1185489-B1 | METHOD FOR PREVENTING UNDESIRED POLYMERISATION IN A MIXTURE OF SUBSTANCES CONTAINING ETHYLENICALLY UNSATURATED COMPOUNDS | BASF AG (DE) | 2004-03-10 | — | — | EP | disclosed |
| US-20040019247-A1 | Continuous recovery of styrene from a styrene-containing mixture | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-29 | — | — | US | disclosed |
| EP-1154974-B1 | METHOD FOR THE CONTINUOUS RECOVERY OF STYRENE FROM A MIXTURE CONTAINING SAME | BASF AG (DE) | 2003-09-10 | — | — | EP | disclosed |
| US-20030060544-A1 | Stabilizer composition | BASF AKTIENGESELLSCHAFT (DE) | 2003-03-27 | — | — | US | disclosed |
| EP-0944563-B1 | SUBSTANCE MIXTURES CONTAINING STABILIZERS AND COMPOUNDS CONTAINING VINYL GROUPS | BASF AG (DE) | 2002-04-03 | — | — | EP | disclosed |
| US-6200460-B1 | MIXTURE COMPRISING VINYL AROMATIC COMPOUND, ACTIVE AMOUNT OF MIXTURE WHICH INHIBITS THE PREMATURE POLYMERIZATION OF SAID COMPOUND COMPRISING NOXYL COMPOUND, IRON COMPOUND, OPTIONALLY NITRO COMPOUNDS AND COSTABILIZERS | BASF AKTIENGESELLSCHAFT (DE) | 2001-03-13 | — | — | US | disclosed |
| EP-0162804-A1 | Substituted dibenzotetraaza-[14]-annulene metal complexes, process for their preparation and their use | CIBA-GEIGY AG (CH) | 1985-11-27 | — | — | EP | disclosed |
| EP-0108181-A1 | Dibenzo(b,i)-1,4,8,11-tetraaza(14)annulenocobalt(III) iodide | CIBA-GEIGY AG (CH) | 1984-05-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040019247-A1 | Continuous recovery of styrene from a styrene-containing mixture | SORD, NEFM, DOHH | ALDH1A1 1014/4885KDM4E 4378/4885MAPT 466/4885 |
| US-20050090703-A1 | Continuous recovery of styrene from a styrene-containing mixture | SORD, NEFM, DOHH | ALDH1A1 1014/4885KDM4E 4378/4885MAPT 466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.